Equities research analysts expect Xylem Inc. (NYSE:XYL) to announce earnings of $0.51 per share for the current quarter, according to Zacks. Six analysts have issued estimates for Xylem’s earnings, with the lowest EPS estimate coming in at $0.50 and the highest estimate coming in at $0.53. Xylem posted earnings per share of $0.39 in the same quarter last year, which suggests a positive year over year growth rate of 30.8%. The company is scheduled to report its next earnings report before the market opens on Tuesday, May 1st.
According to Zacks, analysts expect that Xylem will report full year earnings of $2.92 per share for the current year, with EPS estimates ranging from $2.87 to $2.95. For the next financial year, analysts expect that the company will report earnings of $3.38 per share, with EPS estimates ranging from $3.26 to $3.56. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Xylem.
Xylem (NYSE:XYL) last issued its earnings results on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, hitting the consensus estimate of $0.76. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business’s revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.66 EPS.
In other Xylem news, insider Tomas Brannemo sold 1,151 shares of the business’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $76.41, for a total transaction of $87,947.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Curtis J. Crawford sold 7,948 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $71.77, for a total value of $570,427.96. Following the transaction, the director now owns 55,245 shares of the company’s stock, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Insiders have sold a total of 21,105 shares of company stock valued at $1,540,907 in the last 90 days. Insiders own 0.81% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. boosted its position in Xylem by 16.0% during the 4th quarter. BlackRock Inc. now owns 14,130,060 shares of the industrial products company’s stock worth $963,668,000 after acquiring an additional 1,949,335 shares during the period. Parnassus Investments CA boosted its position in Xylem by 0.8% during the 4th quarter. Parnassus Investments CA now owns 6,063,309 shares of the industrial products company’s stock worth $413,518,000 after acquiring an additional 48,919 shares during the period. Geode Capital Management LLC boosted its position in Xylem by 5.5% during the 4th quarter. Geode Capital Management LLC now owns 2,027,704 shares of the industrial products company’s stock worth $138,016,000 after acquiring an additional 106,271 shares during the period. KAMES CAPITAL plc boosted its position in Xylem by 16.1% during the 4th quarter. KAMES CAPITAL plc now owns 1,098,865 shares of the industrial products company’s stock worth $74,943,000 after acquiring an additional 152,355 shares during the period. Finally, Chilton Investment Co. LLC boosted its position in Xylem by 0.6% during the 4th quarter. Chilton Investment Co. LLC now owns 982,583 shares of the industrial products company’s stock worth $67,012,000 after acquiring an additional 5,627 shares during the period. Institutional investors own 86.02% of the company’s stock.
Shares of XYL opened at $78.88 on Wednesday. The company has a market capitalization of $13,821.18, a PE ratio of 32.87, a PEG ratio of 1.48 and a beta of 1.10. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. Xylem has a 52 week low of $48.97 and a 52 week high of $79.83.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.